MedPath

A study to Compare Different Anesthetic agents as a cause of Delirium after ECT

Not Applicable
Conditions
Health Condition 1: F30-F39- Mood [affective] disordersHealth Condition 2: F20-F29- Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders
Registration Number
CTRI/2023/01/049228
Lead Sponsor
Government Medical College Kota
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients above 18 years of age.

2. Patients whose informed consent has been obtained.

3. Only the first session of ECT during current admission of the patient will be studied.

Exclusion Criteria

1. Patient who have received ECT during the last one year.

2. Patients with clinically significant laboratory abnormality or ECG findings.

3. Patients with delirium.

4. Patients with organic or neurological disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The role of thiopental, propofol, etomidate on Post- ECT delirium and recovery.Timepoint: Patient alertness will be assessed using Richmond Agitation- Sedation Scale and delirium with Confusion Assessment Method for the ICU at 15 min, 30 min and 1 hour after eye opening.
Secondary Outcome Measures
NameTimeMethod
To identify predictors of Post ECT delirium and recovery. <br/ ><br> <br/ ><br>Timepoint: Predictors of Post Electroconvulsive therapy delirium
© Copyright 2025. All Rights Reserved by MedPath